What are the side effects of Elfabrio 2 mg/mL concentrate for solution for infusion?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can Elfabrio 2 mg/mL concentrate for solution for infusion be used during pregnancy?

( AHT ) For the active ingredient pegunigalsidase alfa You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Elfabrio 2 mg/mL concentrate for solution for infusion belong to?

Elfabrio 2 mg/mL concentrate for solution for infusion: ATC A16AB20. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Elfabrio 2 mg/mL concentrate for solution for infusion

INN: PEGUNIGALSIDASE ALFA

Data updated: 2026-04-24

Available in:

🇨🇿🇩🇪🇬🇧🇵🇹🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.